Skip to content
2000
image of Recent Patents and Formulation Strategies for Osmotic Controlled Drug Delivery Systems: A Comprehensive Analysis

Abstract

Introduction

Conventional drug delivery systems often release drugs immediately at an uncontrolled rate, failing to maintain a sustained and effective concentration at the site of action. This limitation necessitates the exploration of more advanced delivery technologies.

Methods

A comprehensive literature review was conducted using databases such as PubMed, Medline, Google Scholar, and patent repositories, including the United States Patent and Trademark Office (USPTO) and the World Intellectual Property Organization (WIPO). The inclusion criteria covered peer-reviewed articles, patents, and relevant studies. Data were extracted using a standardized form to ensure consistency and reliability across sources.

Results

Osmotic-controlled drug delivery systems have demonstrated the ability to overcome limitations of conventional methods by providing sustained drug release over extended periods. Core components of these systems include drugs, osmotic agents, semipermeable membranes, plasticizers, wicking agents, and pore-forming agents. Key formulation parameters such as drug solubility, orifice size, and osmotic pressure play a pivotal role in controlling drug release rates.

Discussion

Various fabrication methods, such as mechanical or laser drilling, indentation, and the inclusion of leaching substances, can be employed to create delivery apertures in osmotic pumps. This review offers insights into both historical and recent patents related to osmotic-controlled delivery systems, highlighting their potential to revolutionize sustained-release formulations.

Conclusion

This review highlights the potential of osmotic-controlled drug delivery systems to improve therapeutic outcomes and patient compliance by enabling sustained and controlled drug release. Key formulation components and recent technological innovations, including patents, are highlighted for their role in enhancing system performance and guiding future pharmaceutical development.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/raddf/10.2174/0126673878393539251118061252
2025-12-20
2026-05-14

  • From This Site

    /content/journals/raddf/10.2174/0126673878393539251118061252
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Ezike T.C. Okpala U.S. Onoja U.L. Nwike C.P. Ezeako E.C. Okpara O.J. Okoroafor C.C. Eze S.C. Kalu O.L. Odoh E.C. Nwadike U.G. Ogbodo J.O. Umeh B.U. Ossai E.C. Nwanguma B.C. Advances in drug delivery systems, challenges and future directions. Heliyon 2023 9 6 e17488 10.1016/j.heliyon.2023.e17488 37416680
    [Google Scholar]
  2. Almoshari Y. Osmotic pump drug delivery systems - A comprehensive review. Pharmaceuticals 2022 15 11 1430 10.3390/ph15111430 36422560
    [Google Scholar]
  3. Keraliya R.A. Patel C. Patel P. Keraliya V. Soni T.G. Patel R.C. Patel M.M. Osmotic drug delivery system as a part of modified release dosage form. ISRN Pharm. 2012 2012 1 9 10.5402/2012/528079 22852100
    [Google Scholar]
  4. Adepu S. Ramakrishna S. Controlled drug delivery systems: Current status and future directions. Molecules 2021 26 19 5905 10.3390/molecules26195905 34641447
    [Google Scholar]
  5. Gupta B.P. Thakur N. Jain N.P. Banweer J. Jain S. Osmotically controlled drug delivery system with associated drugs. J. Pharm. Pharm. Sci. 2010 13 4 571 588 10.18433/J38W25 21486532
    [Google Scholar]
  6. Manning G.S. Kay A.R. The physical basis of osmosis. J. Gen. Physiol. 2023 155 10 e202313332 10.1085/jgp.202313332 37624228
    [Google Scholar]
  7. Sahoo C.K. Sahoo N.K. Rao S.R.M. Sudhakar M. Satyanarayana K. A review on controlled porosity osmotic pump tablets and its evaluation. Bull. Fac. Pharm. Cairo Univ. 2015 53 2 195 205 10.1016/j.bfopcu.2015.10.004
    [Google Scholar]
  8. Syed S.M. Farooqui Z. Mohammed M. Dureshahwar K. Farooqui M. Osmotic drug delivery system: An overview. Int J Pharm Res Allied Sci 2015 4 3 10 20
    [Google Scholar]
  9. Rose S. Nelson J.F. A continuous long-term injector. Immunol. Cell Biol. 1955 33 4 415 420 10.1038/icb.1955.44 13269346
    [Google Scholar]
  10. Singh K. Walia M.K. Agarwal G. Harikumar S.L. Osmotic pump drug delivery system: A noval approach. J. Drug Deliv. Ther. 2013 3 5 156 162 10.22270/jddt.v3i5.636
    [Google Scholar]
  11. Khatri N. Nikam S. Bilandi A. Oral osmotic drug delivery system: A review. Int. J. Pharm. Sci. Res. 2016 7 6 2302 2312
    [Google Scholar]
  12. Garepally P. Goli S. Bontha V.K. Design, development and characterizations of acyclovir osmotic tablets. J. Pharm. Pharmacol. Res. 2018 1 1 1 14
    [Google Scholar]
  13. Herrlich S. Spieth S. Messner S. Zengerle R. Osmotic micropumps for drug delivery. Adv. Drug Deliv. Rev. 2012 64 14 1617 1627 10.1016/j.addr.2012.02.003 22370615
    [Google Scholar]
  14. Rohloff C.M. Alessi T.R. Yang B. Dahms J. Carr J.P. Lautenbach S.D. DUROS technology delivers peptides and proteins at consistent rate continuously for 3 to 12 months. J. Diabetes Sci. Technol. 2008 2 3 461 467 10.1177/193229680800200316 19885211
    [Google Scholar]
  15. Davoodi P. Lee L.Y. Xu Q. Sunil V. Sun Y. Soh S. Wang C.H. Drug delivery systems for programmed and on-demand release. Adv. Drug Deliv. Rev. 2018 132 104 138 10.1016/j.addr.2018.07.002 30415656
    [Google Scholar]
  16. Bansode A.S. Sarvanan K. Review on novel osmotic drug delivery system. J. Drug Deliv. Ther. 2018 8 5-s 87 93 10.22270/jddt.v8i5‑s.1961
    [Google Scholar]
  17. Ketjinda W. Sinchaipanid N. Limsuwan P. Leuenberger H. Mitrevej A. Development of push-pull osmotic tablets using chitosan-poly(acrylic acid) interpolymer complex as an osmopolymer. AAPS PharmSciTech 2011 12 1 132 140 10.1208/s12249‑010‑9572‑z 21181509
    [Google Scholar]
  18. Hu J. Zhang L. Li W. He Y. Wu C.Y. Modelling the controlled drug release of push-pull osmotic pump tablets using DEM. Int. J. Pharm. 2024 660 124316 10.1016/j.ijpharm.2024.124316 38857664
    [Google Scholar]
  19. Koch A.L. Rusnak M. Peachee K. Isaac A. McCart E.A. Rittase W.B. Olsen C.H. Day R.M. Symes A.J. Comparison of the effects of osmotic pump implantation with subcutaneous injection for administration of drugs after total body irradiation in mice. Lab. Anim. 2021 55 2 142 149 10.1177/0023677220939991 32703063
    [Google Scholar]
  20. Dasankoppa FS Ningangowdar M Sholapur H Formulation and evaluation of controlled porosity osmotic pump for oral delivery of ketorolac. J Basic Clin Pharm 2012 4 1 2 9 10.4103/0976‑0105.109398
    [Google Scholar]
  21. Kidane A Bhatt PP Osmotic drug delivery system. US8747897B2 2007
  22. Chen M.L. Sadrieh N. Yu L. Impact of osmotically active excipients on bioavailability and bioequivalence of BCS class III drugs. AAPS J. 2013 15 4 1043 1050 10.1208/s12248‑013‑9509‑z 23868749
    [Google Scholar]
  23. Liu L. Ku J. Khang G. Lee B. Rhee J.M. Lee H.B. Nifedipine controlled delivery by sandwiched osmotic tablet system. J. Control. Release 2000 68 2 145 156 10.1016/S0168‑3659(00)00243‑1 10925123
    [Google Scholar]
  24. Zentner G.M. McClelland G.A. Sutton S.C. Controlled porosity solubility- and resin-modulated osmotic drug delivery systems for release of diltiazem hydrochloride. J. Control. Release 1991 16 1-2 237 243 10.1016/0168‑3659(91)90047‑H
    [Google Scholar]
  25. Rabti H. Mohammed Salmani J.M. Elamin E.S. Lammari N. Zhang J. Ping Q. Carbamazepine solubility enhancement in tandem with swellable polymer osmotic pump tablet: A promising approach for extended delivery of poorly water-soluble drugs. Asian J. Pharm. Sci. 2014 9 3 146 154 10.1016/j.ajps.2014.04.001
    [Google Scholar]
  26. Verma R.K. Garg S. Development and evaluation of osmotically controlled oral drug delivery system of glipizide. Eur. J. Pharm. Biopharm. 2004 57 3 513 525 10.1016/j.ejpb.2004.02.003 15093601
    [Google Scholar]
  27. Theeuwes F. Swanson D.R. Guittard G. Ayer A. Khanna S. Osmotic delivery systems for the beta‐adrenoceptor antagonists metoprolol and oxprenolol: Design and evaluation of systems for once‐ daily administration. Br. J. Clin. Pharmacol. 1985 19 S2 69S 76S.(Suppl. 2) 10.1111/j.1365‑2125.1985.tb02745.x 4005132
    [Google Scholar]
  28. Vijaya C. Goud K.S. Ion-activated in situ gelling ophthalmic delivery systems of azithromycin. Indian J. Pharm. Sci. 2011 73 6 615 620 10.4103/0250‑474X.100234 23112394
    [Google Scholar]
  29. Prabakaran D. Singh P. Kanaujia P. Jaganathan K. Rawat A. Vyas S. Modified push?pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization. Int. J. Pharm. 2004 284 1-2 95 108 10.1016/j.ijpharm.2004.07.015 15454301
    [Google Scholar]
  30. Kumaravelrajan R. Narayanan N. Suba V. Development and evaluation of controlled porosity osmotic pump for Nifedipine and Metoprolol combination. Lipids Health Dis. 2011 10 1 51 10.1186/1476‑511X‑10‑51 21477386
    [Google Scholar]
  31. Stillwell W. Membrane transport. An Introduction to Biological Membranes. Elsevier 2016 10.1016/B978‑0‑444‑63772‑7.00019‑1
    [Google Scholar]
  32. Eslami Z. Elkoun S. Robert M. Adjallé K. A review of the effect of plasticizers on the physical and mechanical properties of alginate-based films. Molecules 2023 28 18 6637 10.3390/molecules28186637 37764413
    [Google Scholar]
  33. Babu A. Rao M.P. Ratna V. Controlled-Porosity osmotic pump tablets – An Overview. Asian J Pharm Res Health Care 2010 2 1 114 126
    [Google Scholar]
  34. Neuse E.W. Synthetic polymers as drug-delivery vehicles in medicine. Met. Based Drugs 2008 2008 1 19 10.1155/2008/469531 18497867
    [Google Scholar]
  35. Monisha A. Varma M.M. Raju D.B. A complete recapitulation of a drug delivery based on osmotic pressure: An osmotic drug delivery system. Int. J. Pharm. Sci. Res. 2021 12 10 5264 5280 10.13040/IJPSR.0975‑8232.12(10).5264‑80
    [Google Scholar]
  36. Aiman Syafiq Mohd Hamidi N. Mohamad Ikhmal Wan Mohamad Kamaruzzaman W. Amirah Mohd Nasir N. Syaizwadi Shaifudin M. Sabri Mohd Ghazali M. Potential application of plant-based derivatives as green components in functional coatings: A review. Cleaner Materials 2022 4 100097 10.1016/j.clema.2022.100097
    [Google Scholar]
  37. Khavare N.B. Dasankoppa F.S. Najundaswamy N.G. A review on key parameters and components in designing of osmotic controlled oral drug delivery systems. Indian J. Nov. Drug Deliv. 2010 2 4 122 131
    [Google Scholar]
  38. Geraili A. Xing M. Mequanint K. Design and fabrication of drug‐delivery systems toward adjustable release profiles for personalized treatment. VIEW 2021 2 5 20200126 10.1002/VIW.20200126
    [Google Scholar]
  39. Dash S. Murthy P.N. Nath L. Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol. Pharm. 2010 67 3 217 223 20524422
    [Google Scholar]
  40. Tomar B.S. Tirumkudulu M.S. Yu W. Berchielli A. Manthena S. Doshi P. A model to predict drug release from a single-layer osmotic controlled-release tablet. J. Drug Deliv. Sci. Technol. 2023 80 104138 10.1016/j.jddst.2022.104138
    [Google Scholar]
  41. Lin W. Li Y. Shi Q. Liao X. Zeng Y. Tian W. Xie X. Liu H. Preparation and evaluation of bilayer-core osmotic pump tablets contained topiramate. PLoS One 2022 17 2 e0264457 10.1371/journal.pone.0264457 35213658
    [Google Scholar]
  42. Kalepu S. Nekkanti V. Insoluble drug delivery strategies: Review of recent advances and business prospects. Acta Pharm. Sin. B 2015 5 5 442 453 10.1016/j.apsb.2015.07.003 26579474
    [Google Scholar]
  43. Kumari L. Choudhari Y. Patel P. Gupta G.D. Singh D. Rosenholm J.M. Bansal K.K. Kurmi B.D. Advancement in solubilization approaches: A step towards bioavailability enhancement of poorly soluble drugs. Life 2023 13 5 1099 10.3390/life13051099 37240744
    [Google Scholar]
  44. Salunke S. O’Brien F. Cheng Thiam Tan D. Harris D. Math M.C. Ariën T. Klein S. Timpe C. European Paediatric Formulation Initiative EuPFI Oral drug delivery strategies for development of poorly water soluble drugs in paediatric patient population. Adv. Drug Deliv. Rev. 2022 190 114507 10.1016/j.addr.2022.114507 36049580
    [Google Scholar]
  45. Kidane A Bhatt PP Osmotic drug delivery system. US Patent 9393203B2 2016
  46. Patel H Patel U Kadikar H Bhimani B Daslaniya D Patel G. A review on osmotic drug delivery system. Preprint 2012 10.13140/RG.2.2.13449.77920
    [Google Scholar]
  47. Rudnic EM Burnside BA Flanner HH Wassink SE Couch RA Pinkett JE Soluble form osmotic dose delivery system. US Patent 6284276 2001
  48. Ghosh T. Ghosh A. Drug delivery through osmotic systems – An overview. J. Appl. Pharm. Sci. 2011 1 2 38 49
    [Google Scholar]
  49. Sharma M. Haye A. Ansari M.A. Saini A. Ahmed Z. Munjal K. Shamsi Y. Polyherbal formulation improves glucose-lipid metabolism and prevent hepatotoxicity in streptozotocin-induced diabetic rats: Plausible role of IRS-PI3K-Akt-GLUT2 signaling. Pharmacogn. Mag. 2022 18 77 52 65 10.4103/pm.pm_318_21
    [Google Scholar]
  50. Swathi B. Manichandrika K.P. Niharika R. Pravalika G. Sahithya D. Meghana M. Formulation and evaluation of quinidine osmotic drug delivery system. Int J Adv Res Med Phar Sci 2019 4 17 22
    [Google Scholar]
  51. Gohel M.R. Shah A. Upadhyay U.M. Formulation development of suitable osmotic drug delivery system for highly water soluble drug. J. Adv. Pharm. Educ. Res. 2014 4 2 193 199
    [Google Scholar]
  52. Abdulwahab A.E. Hubeatir K.A. Imhan K.I. Optimization of PC micro-drilling using a continuous CO2 laser: An experimental and theoretical comparative study. J. Eng. Appl. Sci. (Asian Res. Publ. Netw.) 2022 69 98
    [Google Scholar]
  53. Theeuwes F Higuchi T Osmatic dispensing device for releasing beneficial agent. US Patent 3845770A 1974
  54. Liu L. Che B. Preparation of monolithic osmotic pump system by coating the indented core tablet. Eur. J. Pharm. Biopharm. 2006 64 2 180 184 10.1016/j.ejpb.2006.05.004 16797951
    [Google Scholar]
  55. Broitman E. Indentation hardness measurements at macro-, micro-, and nanoscale: A critical overview. Tribol. Lett. 2017 65 1 23 10.1007/s11249‑016‑0805‑5
    [Google Scholar]
  56. Wang H. Yu H. Tran T.N. Fu K. Kiley K. Kullar S. Hu J. Kamberi M. Chemical characterization of leachables in catheter device. ACS Omega 2022 7 51 48291 48300 10.1021/acsomega.2c06473 36591149
    [Google Scholar]
  57. Nagaraj B. Arjun N. Narendar D. Sunitha K. Harika K. Development, evaluation, and influence of formulation and process variables on in vitro performance of oral nlmary osmotic device of atenolol. Int. J. Pharm. Investig. 2016 6 4 238 246 10.4103/2230‑973X.195951 28123994
    [Google Scholar]
  58. Darji P.K. Patel J.K. Patel B. Parikh S. Fnu P.I.J. Overview on osmotic drug delivery system. Int J Pharm Res Application 2024 9 1 86 100
    [Google Scholar]
  59. Pandey S. Viral D. Osmotic pump drug delivery devices: From implant to sandwiched oral therapeutic system. Int. J. Pharm. Tech. Res. 2010 2 1 693 699
    [Google Scholar]
  60. Suryadevara V. Lankapalli S.R. Vejella U.M.R. Mupparaju S. Chava S. Formulation and evaluation of losartan potassium osmotic controlled matrix tablets. Indian J. Pharm. Edu. Res. 2014 48 Suppl. 18 26 10.5530/ijper.48.4s.3
    [Google Scholar]
  61. Rathore G. Gupta R.N. Formulation development and evaluation of controlled porosity osmotic pump delivery system for oral delivery of atenolol. Asian J. Pharm. 2012 6 2 151 160 10.4103/0973‑8398.102941
    [Google Scholar]
  62. Thakkar H.P. Pancholi N. Patel C.V. Development and evaluation of a once-daily controlled porosity osmotic pump of tapentadol hydrochloride. AAPS PharmSciTech 2016 17 5 1248 1260 10.1208/s12249‑015‑0463‑1 26677859
    [Google Scholar]
  63. Missaghi S. Patel P. Farrell T.P. Huatan H. Rajabi-Siahboomi A.R. Investigation of critical core formulation and process parameters for osmotic pump oral drug delivery. AAPS PharmSciTech 2014 15 1 149 160 10.1208/s12249‑013‑0040‑4 24222269
    [Google Scholar]
  64. Edavalath S. Kalayanappa S. Prakasam K. Rao B.P. Goli D. Formulation development and optimization of controlled porosity osmotic pump tablets of diclofenac sodium. Int. J. Pharm. Pharm. Sci. 2011 3 80 87
    [Google Scholar]
  65. Roy H. Pradhan G. Formulation and evaluation of osmotically controlled delivery of lamivudine tablet. Int J Med Nanotechnol 2015 2 5 295 298
    [Google Scholar]
  66. Mathur M. Mishra R. Mehta T. Bhatt N. Gulati I. Dhall V. Development of controlled porosity osmotic pump of metoprolol succinate: Design, optimization and characterization. J Pharm Sci Res 2015 7 1021 1031
    [Google Scholar]
  67. Li Y. Pan H. Duan H. Chen J. Zhu Z. Fan J. Li P. Yang X. Pan W. Double-layered osmotic pump controlled release tablets of actarit: In vitro and in vivo evaluation. Asian J. Pharm. Sci. 2019 14 3 340 348 10.1016/j.jphs.2019.02.005 32104464
    [Google Scholar]
  68. Bathool A. Gowda D.V. Khan M. Ahmed A. Vasudha S.L. Rohitash K. Development and evaluation of microporous osmotic tablets of diltiazem hydrochloride. J. Adv. Pharm. Technol. Res. 2012 3 2 124 129 10.4103/2231‑4040.97292 22837961
    [Google Scholar]
  69. Zadbuke N.S. Shahi S.R. Gulecha B. Shivanikar S. Shinde S. Design and development of controlled porosity osmotic tablet of diltiazem hydrochloride. J. Adv. Pharm. Technol. Res. 2012 3 4 229 236 10.4103/2231‑4040.104714 23378944
    [Google Scholar]
  70. Xin T. Zhao Y. Jing H. Zhang W. Gao Y. Yang X. Qu X. Pan W. A time-released osmotic pump fabricated by compression-coated method: Formulation screen, mechanism research and pharmacokinetic study. Asian J. Pharm. Sci. 2014 9 4 208 217 10.1016/j.ajps.2014.05.003
    [Google Scholar]
  71. Rudnic EM Burnside BA Flanner HH Wassink SE Couch RA Pinkett JE Osmotic drug delivery system. US Patent 6110498A 2000
  72. Curatolo WJ Friedman HL Korsmeyer RW LeMott SR Controlled-release dosage forms of Azithromycin. US Patent 6068859A 2000
  73. Rudnic EM Burnside BA Flanner HH Wassink SE Couch RA Pinkett JE Soluble form osmotic dose delivery system. US Patent 6361796B1 2002
  74. Rudnic EM Burnside BA Flanner HH Wassink SE Couch RA Pinkett JE Soluble form osmotic dose delivery system. US Patent 6514532B2 2003
  75. Viswanathan NB Sankar R Verma RK Raghuvanshi RS Rampal AK Monocompartment osmotic controlled drug delivery system. WO Patent 2003092660A1 2003
  76. Rudnic EM Burnside BA Flanner HH Wassink SE Couch RA Pinkett JE Osmotic drug delivery system. US Patent 6814979B2 2004
  77. Appel LE Curatolo WJ Herbig SM Nightingale JAS Thombre AG Controlled release by extrusion of solid amorphous dispersions of drugs. US Patent 6706283B1 2004
  78. Flanner HH McKnight LC Burnside BA P. System for osmotic delivery of pharmaceutically active agents. US Patent 6838093B2 2005
  79. Straub J. Bernstein H Chichering DE Khattak S Randall G. Porous drug matrices and methods of manufacture thereof. US Patent 6932983B1 2005
  80. Chen G Lautenbach SD Dionne KE Jordan SD Berry SA Rodenberger CI Ayer R Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems. US Patent 6923800B2 2005
  81. Curatolo WJ Friedman HL Korsmeyer RW LeMott SR Controlled-release dosage forms of azithromycin. US Patent 7108865B2 2006
  82. Fereira PJ Berry SA Osmotic delivery system with early zero order push power engine. US Patent 7074423B2 2006
  83. Kidane A Ray SK Bhatt PP Bryan JW Osmotic delivery of therapeutic compounds by solubility enhancement. US Patent 7611728B2 2009
  84. Appel LE Curatolo WJ Herbig SM Nightingale JAS Thombre AG Controlled release by extrusion of solid amorphous dispersions of drugs. US Patent 7550158B2 2009
  85. Liu JQ Yi Q Xi WL Osmotic pump type controlled release tablets and preparation method thereof. CN Patent 102198112A 2010
  86. Feleder EC Meyer GA Ricci MA Faour J Pastini AC Befumo MF Osmotic device containing a venlafaxine salt and a salt having an ion in common. US Patent 8293799B2 2012
  87. Oshlack B Huang H-P Masselink JK Tonelli AP Controlled release hydrocodone formulations. US Patent 8231898B2 2012
  88. Kidane A Bhatt PP Osmotic drug delivery system. US Patent 8747897B2 2014
  89. Jiang Q Yi W Liu Q Yang W Zheng J Osmotic pump-controlled release tablet and preparation method thereof. US Patent 9005661B2 2015
  90. Oshlack B Huang H-P Masselink JK Tonelli A Methods of providing analgesia. US Patent 9682077B2 2017
  91. Kidane A Bhatt PP Osmotic drug delivery system. US Patent 10154965B2 2018
  92. Zhu J Ma Y Yang Q Chow KY Method for dry powder coating osmotic drug delivery system. US Patent 20190099377A1 2019
  93. Xueying Y Yang Z Shiyi X Yingqi W Xueying W Siyuan W Yan X Nifedipine-captopril timing osmotic pump-controlled release tablet and preparation method thereof. CN Patent 111419812 2020
  94. Xiao K Lirong Y Venlafaxine hydrochloride-containing pharmaceutical composition. CN Patent 112999179 2021
  95. Xiaomin H Xiongfei W Shuaijie H Nifedipine controlled release tablet. CN Patent 114432254 2022
  96. Devin V Mark R.P Sebestien H. Drug delivery devices having separable microneedles and methods. US Patent 12138416B2 2024
  97. Mahari S Najafi SH Masoomzadeh S Kumar S Gholikhani T A review of osmotic pump applications as a reliable drug delivery system in pharmaceutical sciences. Biomed Res Bull 2022 2 1 29 36 10.34172/biomedrb.2024.05
    [Google Scholar]
/content/journals/raddf/10.2174/0126673878393539251118061252
Loading
Recent Patents and Formulation Strategies for Osmotic Controlled Drug Delivery Systems: A Comprehensive Analysis
Bentham Science Publishers ; https://doi.org/10.2174/0126673878393539251118061252
/content/journals/raddf/10.2174/0126673878393539251118061252
/content/journals/raddf/10.2174/0126673878393539251118061252
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: Controlled porosity ; osmotic ; patents ; osmotic controlled drug delivery system ; semipermeable membrane ; orifice

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test